8-Benzoylamino-2-(4-methoxy)phenyl-6-phenylimidazo[1,2-a]pyrazine

ID: ALA4099880

PubChem CID: 137659308

Max Phase: Preclinical

Molecular Formula: C26H20N4O2

Molecular Weight: 420.47

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2cn3cc(-c4ccccc4)nc(NC(=O)c4ccccc4)c3n2)cc1

Standard InChI:  InChI=1S/C26H20N4O2/c1-32-21-14-12-19(13-15-21)23-17-30-16-22(18-8-4-2-5-9-18)27-24(25(30)28-23)29-26(31)20-10-6-3-7-11-20/h2-17H,1H3,(H,27,29,31)

Standard InChI Key:  HCXWEYBARNXDBL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   25.4471   -5.0971    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.4459   -5.9166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1540   -6.3256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1522   -4.6882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8608   -5.0935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8611   -5.9167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.6440   -6.1708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1277   -5.5047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6436   -4.8389    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.1497   -3.8710    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.9417   -5.5030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3499   -6.2122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1664   -6.2122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5755   -5.5039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1623   -4.7940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3472   -4.7974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7398   -6.3249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0321   -5.9141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3246   -6.3214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3235   -7.1395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0358   -7.5485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7405   -7.1388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8562   -3.4603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8538   -2.6431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5652   -3.8668    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.5657   -2.2348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5636   -1.4211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8541   -1.0112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1453   -1.4298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1509   -2.2413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3927   -5.5025    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.8025   -6.2095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  4  1  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  2  0
  4 10  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  8 11  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  2 17  1  0
 10 23  1  0
 23 24  1  0
 23 25  2  0
 24 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 24  1  0
 14 31  1  0
 31 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4099880

    ---

Associated Targets(Human)

TMIGD3 Tchem Transmembrane domain-containing protein TMIGD3 (200 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2B Tclin Adenosine A2b receptor (7672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 420.47Molecular Weight (Monoisotopic): 420.1586AlogP: 5.32#Rotatable Bonds: 5
Polar Surface Area: 68.52Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 1.98CX LogP: 5.14CX LogD: 5.14
Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.42Np Likeness Score: -1.06

References

1. Poli D, Falsini M, Varano F, Betti M, Varani K, Vincenzi F, Pugliese AM, Pedata F, Dal Ben D, Thomas A, Palchetti I, Bettazzi F, Catarzi D, Colotta V..  (2017)  Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes.,  125  [PMID:27721147] [10.1016/j.ejmech.2016.09.076]

Source